4.7 Review

Clinical advances in PET-MRI for breast cancer

期刊

LANCET ONCOLOGY
卷 23, 期 1, 页码 E32-E43

出版社

ELSEVIER SCIENCE INC

关键词

-

类别

资金

  1. Department of Radiology at the University of Wisconsin
  2. Department of Medical Physics at the University of Wisconsin
  3. University of Wisconsin Carbone Cancer Center [P30 CA014520]
  4. National Institutes of Health National Center for Advancing Translational Sciences [UL1TR002373]

向作者/读者索取更多资源

PET-MRI is a hybrid imaging technology that combines the advantages of PET and MRI, which plays an important role in the early diagnosis, staging, prognosis, tumor phenotyping, and assessment of treatment response in breast cancer.
Imaging is paramount for the early detection and clinical staging of breast cancer, as well as to inform management decisions and direct therapy. PET-MRI is a quantitative hybrid imaging technology that combines metabolic and functional PET data with anatomical detail and functional perfusion information from MRI. The clinical applicability of PET-MRI for breast cancer is an active area of research. In this Review, we discuss the rationale and summarise the clinical evidence for the use of PET-MRI in the diagnosis, staging, prognosis, tumour phenotyping, and assessment of treatment response in breast cancer. The continued development and approval of targeted radiopharmaceuticals, together with radiomics and automated analysis tools, will further expand the opportunity for PET-MRI to provide added value for breast cancer imaging and patient care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据